PPT-Cangrelor in Patients with Coronary Artery Disease Pre-treated with Ticagrelor: The Switching

Luis OrtegaPaz MD PhD 1 Francesco Franchi MD 1 Fabiana Rollini MD1 Mattia Galli MD 1 2 Latonya Been AAS 1 Ghussan Ghanem MD 1 Awss Shalhoub MD 1 Tiffany Ossi MD. PLAT. elet Inhibition and patient . O. utcomes trial. Outcomes in patients with a Planned Invasive Strategy. The PLATO trial was funded by AstraZeneca. Invasive. PLATO background. In STEMI and UA/NSTEMI, current guidelines recommend 12 months of aspirin and clopidogrel. Ray P. . Aswat. , M.D.. Adult Cardiology Fellow. Background. Coronary Artery Bypass Graft (CABG) is recommended for patients with left main disease and the preferred revascularization strategy for patients with multi-vessel coronary disease, with depressed systolic function, Left Ventricular Ejection Fraction (LVEF) < 50%, and diabetes.. Coronary Artery Disease & Acute Coronary Syndrome Anthony J. Viera, MD, MPH, FAHA Professor and Chair Objectives Describe the appropriate work-up for chest pain based on clinical factors Know the first-line medications for CAD and recognize important side effects and contraindications Pictorial Presentation. Mike Clark, M.D.. Figure 18.7a. Right. ventricle. Right. coronary. artery. Right. atrium. Right. marginal. artery. Posterior. interventricular. artery. Anterior. interventricular. Associate Professor of Clinical Pharmacy,. SBMU. CLASSIFICATION OF ANTIPLATELET AGENTS. Cyclooxygenase inhibitors. Aspirin. Platelet . P2Y12 receptor . blockers. clopidogrel, . ticlopidine. , . ticagrelor. worldwide with age being the . most important . non-modifiable . risk . factor. . Prevalence of CAD in adults under 30 has been estimated to be very low . (Fig. 1. ), . however its true prevalence is unknown.. vs.. . c. oronary artery bypass for multi-vessel disease: a meta-analysis. . Nirav C Patel MD, Jonathan M Hemli MD, Karthik Seetharam MD, Annapoorna Uttara BS, Derek R Brinster MD,. . Luigi Pirelli MD, Chad . in Patients with End-stage Renal Disease on Hemodialysis. Sarah Nisivaco. 1. , Brooke Patel. 1. , Kaitlin Grady. 1. , Husam H Balkhy. 1. 1. Department of Surgery, University of Chicago Medicine, Chicago, IL, USA. Rajesh . Tota-Maharaj. , Michael J . Blaha. , . Ron . Blankstein. , . Leslee. J Shaw, . Roger . S Blumenthal, . Matthew . J . Budoff. , . Khurram. . Nasir. .. No disclosures for this presentation.. of Iowa, Iowa City; and Washington State University, Spokane.This study was approved by the institutional review board ateach participating center. Investigators at each center recordedpatient informa Positive Gensini Score ABSTRACT This study aims to research whether gensini scoring of white blood cells and their subgroups and hemoglobin (Hb), hematocrit (Htc), erythroscyte and their computatio Cangrelor. : Not the CHAMPION We Hoped For. James Coons, PharmD, FCCP, FACC, BCCP. UPMC Presbyterian Hospital. University of Pittsburgh. Disclosures. Nothing to disclose. CHAMPION Trials Experience. Study. Dr. . . Zaki. . Bettamer. Zikoecho@yahoo.com. February 15, 2019. 50 years old male K/C DM , HTN And smoker. C/O central . ch.. Pain , 3 . wks. duration, radiate to Lt. arm ↑ with . Exercion. & ↓ by rest, staying less than 15 min. no sweating , no vomiting.. Malhar Agarwal, MD, Megha Kureti, MD, Deepa Nagaraju, MD, Mustafa . Wali. , MD, . Zubair. Shaikh, MD, . Maryuri. . Briceno. , MD, Ahmed Nawaz, MD, Jae Youn Moon, MD, . PhD, Latonya . Been, AAS, Siva Suryadevara, MD, Daniel Soffer, MD, Martin M Zenni, .